527 related articles for article (PubMed ID: 33362759)
1. Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020).
Kim DS; Rowland-Jones S; Gea-Mallorquí E
Front Immunol; 2020; 11():571481. PubMed ID: 33362759
[TBL] [Abstract][Full Text] [Related]
2. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
3. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T
Front Immunol; 2022; 13():817905. PubMed ID: 35185909
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.
Kingstad-Bakke B; Lee W; Chandrasekar SS; Gasper DJ; Salas-Quinchucua C; Cleven T; Sullivan JA; Talaat A; Osorio JE; Suresh M
Proc Natl Acad Sci U S A; 2022 May; 119(20):e2118312119. PubMed ID: 35561224
[TBL] [Abstract][Full Text] [Related]
5. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
[TBL] [Abstract][Full Text] [Related]
6. Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies.
Amodio D; Ruggiero A; Sgrulletti M; Pighi C; Cotugno N; Medri C; Morrocchi E; Colagrossi L; Russo C; Zaffina S; Di Matteo G; Cifaldi C; Di Cesare S; Rivalta B; Pacillo L; Santilli V; Giancotta C; Manno EC; Ciofi Degli Atti M; Raponi M; Rossi P; Finocchi A; Cancrini C; Perno CF; Moschese V; Palma P
Front Immunol; 2021; 12():727850. PubMed ID: 34671350
[TBL] [Abstract][Full Text] [Related]
7. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H
mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582
[TBL] [Abstract][Full Text] [Related]
8. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N
Front Immunol; 2021; 12():636768. PubMed ID: 33777028
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
10. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
Front Immunol; 2021; 12():726960. PubMed ID: 34671348
[TBL] [Abstract][Full Text] [Related]
11. A single subcutaneous or intranasal immunization with adenovirus-based SARS-CoV-2 vaccine induces robust humoral and cellular immune responses in mice.
Kim E; Weisel FJ; Balmert SC; Khan MS; Huang S; Erdos G; Kenniston TW; Carey CD; Joachim SM; Conter LJ; Weisel NM; Okba NMA; Haagmans BL; Percivalle E; Cassaniti I; Baldanti F; Korkmaz E; Shlomchik MJ; Falo LD; Gambotto A
Eur J Immunol; 2021 Jul; 51(7):1774-1784. PubMed ID: 33772778
[TBL] [Abstract][Full Text] [Related]
12. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.
Ahluwalia P; Vaibhav K; Ahluwalia M; Mondal AK; Sahajpal N; Rojiani AM; Kolhe R
Front Immunol; 2021; 12():660019. PubMed ID: 34046033
[TBL] [Abstract][Full Text] [Related]
13. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.
Jung MK; Shin EC
Mol Cells; 2021 Jun; 44(6):401-407. PubMed ID: 34120892
[TBL] [Abstract][Full Text] [Related]
14. Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology.
Khanolkar A
Cells; 2021 Dec; 11(1):. PubMed ID: 35011627
[TBL] [Abstract][Full Text] [Related]
15. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Arunachalam PS; Walls AC; Golden N; Atyeo C; Fischinger S; Li C; Aye P; Navarro MJ; Lai L; Edara VV; Röltgen K; Rogers K; Shirreff L; Ferrell DE; Wrenn S; Pettie D; Kraft JC; Miranda MC; Kepl E; Sydeman C; Brunette N; Murphy M; Fiala B; Carter L; White AG; Trisal M; Hsieh CL; Russell-Lodrigue K; Monjure C; Dufour J; Spencer S; Doyle-Meyers L; Bohm RP; Maness NJ; Roy C; Plante JA; Plante KS; Zhu A; Gorman MJ; Shin S; Shen X; Fontenot J; Gupta S; O'Hagan DT; Van Der Most R; Rappuoli R; Coffman RL; Novack D; McLellan JS; Subramaniam S; Montefiori D; Boyd SD; Flynn JL; Alter G; Villinger F; Kleanthous H; Rappaport J; Suthar MS; King NP; Veesler D; Pulendran B
Nature; 2021 Jun; 594(7862):253-258. PubMed ID: 33873199
[TBL] [Abstract][Full Text] [Related]
16. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
Front Immunol; 2021; 12():797919. PubMed ID: 34975908
[TBL] [Abstract][Full Text] [Related]
17. A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains.
Gao F; Huang J; Li T; Hu C; Shen M; Mu S; Luo F; Song S; Hao Y; Wang W; Han X; Qian C; Wang Y; Wu R; Li L; Li S; Jin A
Front Immunol; 2021; 12():789905. PubMed ID: 34950151
[TBL] [Abstract][Full Text] [Related]
18. Rapid and stable mobilization of CD8
Oberhardt V; Luxenburger H; Kemming J; Schulien I; Ciminski K; Giese S; Csernalabics B; Lang-Meli J; Janowska I; Staniek J; Wild K; Basho K; Marinescu MS; Fuchs J; Topfstedt F; Janda A; Sogukpinar O; Hilger H; Stete K; Emmerich F; Bengsch B; Waller CF; Rieg S; Sagar ; Boettler T; Zoldan K; Kochs G; Schwemmle M; Rizzi M; Thimme R; Neumann-Haefelin C; Hofmann M
Nature; 2021 Sep; 597(7875):268-273. PubMed ID: 34320609
[TBL] [Abstract][Full Text] [Related]
19. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates.
Zabaleta N; Dai W; Bhatt U; Hérate C; Maisonnasse P; Chichester JA; Sanmiguel J; Estelien R; Michalson KT; Diop C; Maciorowski D; Dereuddre-Bosquet N; Cavarelli M; Gallouët AS; Naninck T; Kahlaoui N; Lemaitre J; Qi W; Hudspeth E; Cucalon A; Dyer CD; Pampena MB; Knox JJ; LaRocque RC; Charles RC; Li D; Kim M; Sheridan A; Storm N; Johnson RI; Feldman J; Hauser BM; Contreras V; Marlin R; Tsong Fang RH; Chapon C; van der Werf S; Zinn E; Ryan A; Kobayashi DT; Chauhan R; McGlynn M; Ryan ET; Schmidt AG; Price B; Honko A; Griffiths A; Yaghmour S; Hodge R; Betts MR; Freeman MW; Wilson JM; Le Grand R; Vandenberghe LH
Cell Host Microbe; 2021 Sep; 29(9):1437-1453.e8. PubMed ID: 34428428
[TBL] [Abstract][Full Text] [Related]
20. Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.
Duarte LF; Gálvez NMS; Iturriaga C; Melo-González F; Soto JA; Schultz BM; Urzúa M; González LA; Vázquez Y; Ríos M; Berríos-Rojas RV; Rivera-Pérez D; Moreno-Tapia D; Pacheco GA; Vallejos OP; Hoppe-Elsholz G; Navarrete MS; Rojas Á; Fasce RA; Fernández J; Mora J; Ramírez E; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Bueno SM; Kalergis AM
Front Immunol; 2021; 12():742914. PubMed ID: 34659237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
